Life
Briefing: U.S. Senator Probes FDA Amid BioNTech Founders' Departure
Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.
editorial-staff
1 min read
Updated about 1 month ago
Summary
- U.S. senator investigates FDA's actions.
- BioNTech founders to establish a new company.
- Focus on mRNA technology for future vaccines.
Key Facts
| Fact | Value |
|---|---|
| Date | March 10, 2026 |
| Source | STAT |